CellCentric
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Chesterford Research Park, Little Cheste...Phone Number
+44 1799531130Website
www.cellcentric.comRevenue
$9.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About CellCentric
CellCentric is a clinical-stage biotechnology company focused on the development of a novel drug to treat specific cancers. CellCentric was founded in 2003 and is based in Cambridge, the United Kingdom.Explore more
CellCentric Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CellCentric your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on CellCentric recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at CellCentric
Check out if CellCentric is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
CellCentric, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if CellCentric had a recent Job posting/layoffs
Check if CellCentric has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once CellCentric has new funding data
Product Launch: Get notified when CellCentric launches new products
Recommended Actions
Reach out to Masked Content who joined CellCentric as Masked Content
Find 2 more new buyers
Compare Similar Companies to CellCentric
Compare insights from companies similar to CellCentric, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CellCentric is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CellCentric is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CellCentric.
CellCentric financials insights
Gather financial insights about CellCentric, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Unspecified
$26M
2020
Unspecified
$33M
2023
Other Financing Round
$25M
2025
Series C
$120M
2026
Series D
$220M
CellCentric Tech Stack
A closer look at the technologies used by CellCentric
Most Recent Scoops
Funding
Funding
Project
Laboratory Operations, Medical Research, Clinical Operations
Hiring Plans
CellCentric has more open roles in Medical & Health than it has had at any time in the past 12 months.
Hiring Plans
Open Position
Open Position
CellCentric News & Media
Goodwin Advises CellCentric on Oversubscribed $220 Million Series D Financing | News & Events
Goodwin's Life Sciences team advised CellCentric, a biotechnology company advancing Inobrodib, on the completion of a Series D financing. Learn more.CellCentric raises $220M for a 'transformative' multiple myeloma medicine
A Series D round led by Venrock will support an ongoing Phase 2 study, and planned Phase 3 trial, of an oral drug the biotech sees as a differentiated option for patients with persistent disease.CellCentric Announces Oversubscribed $220 Million Series D Financing to Advance Pivotal ...
CAMBRIDGE, England & BOSTON, May 06, 2026--CellCentric, a clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma, today announced the completion of an oversubscribed $220 million Series D financing. The financing was led by specialist investor Venrock Healthcare Capital Partners, with participation from a strong syndicate of new and existing investors.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding CellCentric
Sign Up For FreeTo access detailed company insights
CellCentric is a clinical-stage biotechnology company focused on the development of a novel drug to treat specific cancers. CellCentric was founded in 2003 and is based in Cambridge, the United Kingdom.... Read More
